Early Autism Screening & Diagnosis

Are You or Your Pediatrician Concerned about Autism?

Early detection and intervention is key. Let us point you in the right direction to help you understand, take action, and build a brighter path for your child’s growth and development.

How EarliPoint Helps

When you have questions about your child’s development, you want clear information and trusted guidance. Here are just a few ways EarliPoint Health helps make that process a little easier:

Find a Provider Near You

Use our Provider Directory to connect with a qualified provider who offers evaluations using the EarliPoint System.

Take the Evaluation

Complete an objective assessment that measures both patterns of eye movement and visual attention in young children.

Review with a Clinician

A qualified clinician will interpret your data to provide an evidence-based understanding of your child’s developmental profile.

Discuss Next Steps

Review your child’s results with your clinician, explore treatment and support options, and plan the most appropriate path forward.

Autism Screening Tool

The Modified Checklist for Autism in Toddlers (M-CHAT) is a free, evidence-based screening tool designed for children between 16 and 30 months old. It helps identify signs that may warrant a closer look by a healthcare provider.

You can take the screening online or with your pediatrician—it only takes a few minutes and can provide valuable insights into your child’s development.

What Is Autism?

Autism spectrum disorder (ASD) refers to a broad range of developmental differences that can affect how a child communicates, interacts, and learns. Every child’s experience is unique—some may show clear differences in social communication, while others might display subtle patterns in play, attention, or routines.

Diagnosis is based on careful behavioral observation and developmental evaluation by qualified clinicians. Early evaluation helps families understand their child’s strengths and needs, and ensures they can access support as soon as possible.

Early Warning Signs

Children develop at different rates, but certain signs may indicate that a child could benefit from a developmental evaluation. You or your pediatrician may notice:

If you observe several of these behaviors—or simply feel unsure about your child’s development—it’s important to bring your concerns to your pediatrician. Early conversations make a difference.

What Is Early Intervention?

Early intervention refers to specialized services—such as speech therapy, occupational therapy, or developmental support—designed to help young children build essential skills during their most formative years. The earlier support begins, the greater the opportunity for growth in communication, learning, and daily interaction.

Your pediatrician can guide you through the next steps if your child qualifies for services.

Frequently Asked Questions

What should I do if I’m concerned about my child’s development?

Schedule a comprehensive evaluation with a qualified clinician. To find a provider who uses the EarliPoint System, visit our Provider Directory and enter your city or ZIP code to see locations near you.

How early can my child be tested?

The EarliPoint System is indicated for use in children 16 to 30 months old who are considered at risk based on concerns identified by a parent, caregiver, or healthcare provider.

Why is early evaluation important?

Early evaluation helps families access support and resources sooner. When developmental differences are identified early, children can begin receiving services and interventions during the most critical years for learning and growth.

What happens during an EarliPoint assessment?

Your child simply watches short, engaging videos while the system tracks their eye movements. The process is safe, quick, and noninvasive.

How long does the assessment take?

The EarliPoint assessment requires approximately 15 minutes of viewing time. Before the assessment begins, your clinician will walk your child through a setup and preparation process. After the viewing portion, your clinician will review and discuss the results with you. Overall appointment length may vary depending on your child’s needs and the clinic’s evaluation procedures.

What happens after the evaluation?

A qualified clinician will review the results with you, explain what the data show, and discuss next steps—whether that’s continued monitoring, referrals for additional services, or starting a treatment plan.

Find a Provider Near You

Check out our provider directory to find a clinic or healthcare professional using the EarliPoint System near you. Connecting with a qualified clinician can help you schedule an evaluation sooner and get clear, trusted insights about your child’s development.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder